With solutions spanning ultrasound, X-ray, and MRI, ContextVision’s cutting-edge image enhancement software is designed to deliver unparalleled image clarity, empowering medical professionals worldwide.
At the forefront of their showcase is the enhanced Altumira™ series – a software solution for X-ray imaging. Powered by AI, Altumira™ for static imaging now features a new, impressive scatter correction functionality, enabling a significantly lower radiation dose with gridless acquisition.
Moreover, Altumira™ Plus, for dynamic imaging, will be upgraded with improved noise suppression and enhanced visualization of details, e.g., stents and vessels.
These new features add value to interventional cardiovascular procedures performed with mobile c-arms and angiography systems. These new innovations – and more – will be presented at CMEF (China International Medical Equipment Fair) in Shanghai, April 11–14, 2024.
“Our market-leading X-ray solution Altumira™ works with the context of the image, which means it can be used with all kinds of applications and systems,” says Daniel Alamidi, Product Manager for X-ray.” ContextVision’s products are anything but off-the-shelf. Instead, we tailor them to each customer’s specific context, application, technology, and hardware – right down to the smallest detail.”
Visit ContextVision at CMEF, National Center for Exhibition and Convention, Shanghai (Hall 5.2H, Booth 5.2P54) to discover how their groundbreaking technology is revolutionizing medical imaging. To arrange a meeting with ContextVision at CMEF 2024, please contact John Xie, Sales Director China, at john.xie@contextvision.com. For media inquiries, please contact: Helen Han at helen.han@e21mm.cn
____
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. The company’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China, and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX. www.contextvision.com